Peijia Medical Limited (FRA:4WO)

Germany · Delayed Price · Currency is EUR

0.6550

+0.0250 (3.97%)

Last updated: Feb 20, 2026, 8:55 AM CET

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Neurointerventional Business	355.55M	255.56M	143.52M	94.59M	38.66M
Neurointerventional Business Growth	39.13%	78.06%	51.73%	144.71%	106.72%
Transcatheter Valve Therapeutic Business	259.94M	185.57M	107.31M	41.94M	-
Transcatheter Valve Therapeutic Business Growth	40.07%	72.93%	155.86%	-	-
Total	615.48M	441.13M	250.83M	136.53M	38.66M
Total Growth	39.53%	75.86%	83.71%	253.21%	106.72%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	615.48M	441.13M	250.83M	136.53M	38.66M
China Growth	39.53%	75.86%	83.71%	253.21%	106.72%
Total	615.48M	441.13M	250.83M	136.53M	38.66M
Total Growth	39.53%	75.86%	83.71%	253.21%	106.72%

Source: S&P Global Market Intelligence.